Silence Therapeutics Highlights Recent Business Achievements and Reports Third Quarter 2026 Financial Results
LONDON--(BUSINESS WIRE)-- Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company d
LONDON--(BUSINESS WIRE)-- Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company d